Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B P Poschel

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Life Sciences|October 15, 1974
Intracranial reward after 5,6-dihydroxytryptamine: further evidence for serotonin's inhibitory roleB P Poschel, F W Ninteman, J R McLean, et al.
Experientia|September 15, 1985
Pharmacologic therapeutic window of pramiracetam demonstrated in behavior, EEG, and single neuron firing ratesB P Poschel, P M Ho, F W Ninteman, et al.
Electroencephalography and Clinical Neurophysiology|February 1, 1987
Growing familiarity with the test situation augments the vigilance deficit of aged ratsB P Poschel, P M Ho, M J Callahan, et al.
Journal of Medicinal Chemistry|May 1, 1985
1-[3-(Diarylamino)propyl]piperidines and related compounds, potential antipsychotic agents with low cataleptogenic profilesL D Wise, I C Pattison, D E Butler, et al.
Journal of Medicinal Chemistry|December 1, 1985
Examination of a series of 8-[3-[bis(4-fluorophenyl)amino]propyl]-1-aryl-1,3,8- triazaspiro[4.5]decan-4-ones as potential antipsychotic agentsL D Wise, I C Pattison, D E Butler, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Life Sciences|October 15, 1974
Intracranial reward after 5,6-dihydroxytryptamine: further evidence for serotonin's inhibitory roleB P Poschel, F W Ninteman, J R McLean, et al.
Experientia|September 15, 1985
Pharmacologic therapeutic window of pramiracetam demonstrated in behavior, EEG, and single neuron firing ratesB P Poschel, P M Ho, F W Ninteman, et al.
Electroencephalography and Clinical Neurophysiology|February 1, 1987
Growing familiarity with the test situation augments the vigilance deficit of aged ratsB P Poschel, P M Ho, M J Callahan, et al.
Journal of Medicinal Chemistry|May 1, 1985
1-[3-(Diarylamino)propyl]piperidines and related compounds, potential antipsychotic agents with low cataleptogenic profilesL D Wise, I C Pattison, D E Butler, et al.
Journal of Medicinal Chemistry|December 1, 1985
Examination of a series of 8-[3-[bis(4-fluorophenyl)amino]propyl]-1-aryl-1,3,8- triazaspiro[4.5]decan-4-ones as potential antipsychotic agentsL D Wise, I C Pattison, D E Butler, et al.
Pageof 2